staurosporine has been researched along with Keloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furue, M; Miwa, Y; Morimoto, S; Nakazono-Kusaba, A; Sasaguri, T; Takahashi-Yanaga, F | 1 |
| Chodon, T; Funayama, E; Furukawa, H; Igawa, HH; Sugihara, T | 1 |
2 other study(ies) available for staurosporine and Keloid
| Article | Year |
|---|---|
PKC412 induces apoptosis through a caspase-dependent mechanism in human keloid-derived fibroblasts.
Topics: Apoptosis; Caspase 3; Caspase Inhibitors; Caspases; Cells, Cultured; Enzyme Inhibitors; Female; Fibroblasts; Humans; Keloid; Staurosporine | 2004 |
Keloid-derived fibroblasts are refractory to Fas-mediated apoptosis and neutralization of autocrine transforming growth factor-beta1 can abrogate this resistance.
Topics: Antibodies; Apoptosis; Autocrine Communication; bcl-2-Associated X Protein; bcl-X Protein; Caspases; Cells, Cultured; Drug Resistance; Enzyme Activation; fas Receptor; Fibroblasts; Humans; Keloid; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2000 |